Trade GKOS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Glaukos Corporation (GKOS) is trading at US$165.50, down 1.50% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$10.91B. Over the past 52 weeks, GKOS has traded between US$73.16 and US$191.62. On Syfe you can trade GKOS with $0 commission and add it to your watchlist.
| Previous close | US$168.02 |
|---|---|
| Market cap | US$10.91B |
| P/E ratio | 483.49 |
| 52-week range | US$73.16 – US$191.62 |
| Volume | 850.13K |
| Exchange | US |
Glaukos Corporation
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Year: 2015
Glaukos Insider Sold Shares Worth $2,483,104, According to a Recent SEC Filing
Sep 2, 8:05 AM · MT Newswires
Glaukos Insider Sold Shares Worth $10,784,659, According to a Recent SEC Filing
Aug 14, 7:56 AM · MT Newswires
Glaukos Corporation (GKOS) stock is trading at US$165.50, -1.50% from the previous close of US$168.02.
The market cap for Glaukos Corporation (GKOS) stock is approximately US$10.91B.
The price-to-earnings ratio for Glaukos Corporation (GKOS) is 483.49, based on the latest reported earnings.
The 52-week high for Glaukos Corporation (GKOS) stock is US$191.62.
The 52-week low for Glaukos Corporation (GKOS) stock is US$73.16.
Glaukos Corporation (GKOS) does not currently pay a dividend.
Stay on top of GKOS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
